Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Tardive Dyskinesia
NCT03254186Phase 3Withdrawn
- Sponsor
- Emory University
- Start
- Sep 2017
- Primary completion
- Feb 2019
01
Overview
A Phase 3 trial of propranolol in tardive dyskinesia (TD), sponsored by Emory University. Planned start Sep 2017; status: withdrawn.
02
Drugs
propranolol
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT03254186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03254186.